Literature DB >> 27114755

Diabetes epidemic sweeping the Arab world.

Bisher Abuyassin1, Ismail Laher1.   

Abstract

The prevalence of type-2 diabetes mellitus (T2DM) has increased dramatically during the last 2 decades, a fact driven by the increased prevalence of obesity, the primary risk factor for T2DM. The figures for diabetes in the Arab world are particularly startling as the number of people with diabetes is projected to increase by 96.2% by 2035. Genetic risk factors may play a crucial role in this uncontrolled raise in the prevalence of T2DM in the Middle Eastern region. However, factors such as obesity, rapid urbanization and lack of exercise are other key determinants of this rapid increase in the rate of T2DM in the Arab world. The unavailability of an effective program to defeat T2DM has serious consequences on the increasing rise of this disease, where available data indicates an unusually high prevalence of T2DM in Arabian children less than 18 years old. Living with T2DM is problematic as well, since T2DM has become the 5(th) leading cause of disability, which was ranked 10(th) as recently as 1990. Giving the current status of T2DM in the Arab world, a collaborative international effort is needed for fighting further spread of this disease.

Entities:  

Keywords:  Arab world; Diabetes; Epidemiology; Etiology; Risk factors and complication

Year:  2016        PMID: 27114755      PMCID: PMC4835661          DOI: 10.4239/wjd.v7.i8.165

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  99 in total

1.  Epidemiology of Type 2 diabetes mellitus in Aleppo, Syria.

Authors:  Nizar Albache; Radwan Al Ali; Samer Rastam; Fouad M Fouad; Fawaz Mzayek; Wasim Maziak
Journal:  J Diabetes       Date:  2009-11-02       Impact factor: 4.006

2.  Prevalence and correlates of adult overweight in the Muslim world: analysis of 46 countries.

Authors:  D Kahan
Journal:  Clin Obes       Date:  2015-03-06

3.  Prevalence of overweight and obesity in diabetic and non-diabetic Saudis.

Authors:  M A el-Hazmi; A S Warsy
Journal:  East Mediterr Health J       Date:  2000 Mar-May       Impact factor: 1.628

Review 4.  Physical activity and diabetes prevention.

Authors:  Michael J LaMonte; Steven N Blair; Timothy S Church
Journal:  J Appl Physiol (1985)       Date:  2005-09

5.  Prevalence of blindness and visual impairment among Jordanian diabetics.

Authors:  M I Al-Till; M D Al-Bdour; K M Ajlouni
Journal:  Eur J Ophthalmol       Date:  2005 Jan-Feb       Impact factor: 2.597

6.  The prevalence of diabetes mellitus in male Saudi Arabs.

Authors:  R A Bacchus; J L Bell; M Madkour; B Kilshaw
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

7.  Predictors of incident diabetes mellitus in Basrah, Iraq.

Authors:  Abbas Ali Mansour; Meelad Imad Al-Jazairi
Journal:  Ann Nutr Metab       Date:  2007-07-09       Impact factor: 3.374

8.  Central obesity among adults in Egypt: prevalence and associated morbidity.

Authors:  M A Abolfotouh; L A Soliman; E Mansour; M Farghaly; A A El-Dawaiaty
Journal:  East Mediterr Health J       Date:  2008 Jan-Feb       Impact factor: 1.628

9.  Risk Factors for Diabetic Retinopathy among Jordanian Diabetics.

Authors:  Muawyah D Al-Bdour; Maha I Al-Till; Khawla M Abu Samra
Journal:  Middle East Afr J Ophthalmol       Date:  2008-04

10.  Prevalence and causes of blindness and diabetic retinopathy in Southern Saudi Arabia.

Authors:  Saad Hajar; Ali Al Hazmi; Mustafa Wasli; Ahmed Mousa; Mansour Rabiu
Journal:  Saudi Med J       Date:  2015-04       Impact factor: 1.484

View more
  48 in total

Review 1.  Middle East Medicinal Plants in the Treatment of Diabetes: A Review.

Authors:  Alaa M Abu-Odeh; Wamidh H Talib
Journal:  Molecules       Date:  2021-01-31       Impact factor: 4.411

Review 2.  Diabetes in the Middle East: Government Health Care Policies and Strategies that Address the Growing Diabetes Prevalence in the Middle East.

Authors:  Noor Al Busaidi; Prakash Shanmugam; Deepa Manoharan
Journal:  Curr Diab Rep       Date:  2019-02-04       Impact factor: 4.810

3.  Leptin and the GA genotype of rs2167270 of the LEP gene increase the risk of prediabetes.

Authors:  Mukhallad A Aljanabi; Mahmoud A Alfaqih; Mariam Khanfar; Zouhair O Amarin; Lina Elsalem; Rami Saadeh; Faheem Al-Mughales
Journal:  Biomed Rep       Date:  2021-03-09

4.  Bisphenol A urinary level, its correlates, and association with cardiometabolic risks in Lebanese urban adults.

Authors:  Youssef Mouneimne; Mona Nasrallah; Nathalie Khoueiry-Zgheib; Lara Nasreddine; Nancy Nakhoul; Hussein Ismail; Mohamad Abiad; Lynn Koleilat; Hani Tamim
Journal:  Environ Monit Assess       Date:  2017-09-23       Impact factor: 2.513

Review 5.  Health Benefits of Fasting and Caloric Restriction.

Authors:  Saeid Golbidi; Andreas Daiber; Bato Korac; Huige Li; M Faadiel Essop; Ismail Laher
Journal:  Curr Diab Rep       Date:  2017-10-23       Impact factor: 4.810

Review 6.  Food Labeling Use by Consumers in Arab countries: A Scoping Review.

Authors:  Nada Benajiba; Lana Mahrous; Joshua Bernstein; Basil H Aboul-Enein
Journal:  J Community Health       Date:  2020-06

7.  Protective potential of Opuntia microdasys flower decoction on fructose-alloxan-induced diabetic rats on kidney and pancreas: chemical and immunohistochemical analyses.

Authors:  Hassiba Chahdoura; Aida Khlifi; Jihéne Ben Lamine; Borhane Eddine Cherif Ziani; Khawla Adouni; Safia El Bok; Zohra Haouas; Fadoua Neffati; Abdelfattah Zakhama; Guido Flamini; Lotfi Achour
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-01       Impact factor: 4.223

Review 8.  Efficacy of Low-Carbohydrate Ketogenic Diet in the Treatment of Type 2 Diabetes.

Authors:  Hussain M Dashti; Thazhumpal C Mathew; Naji S Al-Zaid
Journal:  Med Princ Pract       Date:  2020-10-09       Impact factor: 1.927

9.  Diabetic Foot Disease Research in Gulf Cooperation Council Countries: A bibliometric analysis.

Authors:  Ibrahim S Al-Busaidi; Nadia N Abdulhadi; Kirsten J Coppell
Journal:  Sultan Qaboos Univ Med J       Date:  2018-12-19

10.  Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.

Authors:  Kamlesh Khunti; Mikhail Kosiborod; Dae Jung Kim; Shun Kohsaka; Carolyn S P Lam; Su-Yen Goh; Chern-En Chiang; Jonathan E Shaw; Matthew A Cavender; Navdeep Tangri; Josep Franch-Nadal; Reinhard W Holl; Marit E Jørgensen; Anna Norhammar; Johan G Eriksson; Francesco Zaccardi; Avraham Karasik; Dianna J Magliano; Marcus Thuresson; Hungta Chen; Eric Wittbrodt; Johan Bodegård; Filip Surmont; Peter Fenici
Journal:  Cardiovasc Diabetol       Date:  2021-07-31       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.